Income from royalties and supply of vivagel $1m.
Cost of goods sold $650k
Surplus $350k. This will include a margin on supply of product with remainder being royalties received for 6 months.
We have a long, long way to go. The pace of product launch in approved regions seems very slow. Aspen particularly need a bomb up their clacker.
Dep trials -- Cut and paste info. Anyone who thinks the Ph 2 will be complete by mid year is dreaming. They are still recruiting now as obviously they are exploring areas not on the agenda at trial commencement. This however should be seen as a positive.
Income from royalties and supply of vivagel $1m.Cost of goods...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.001(1.02%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 9.6¢ | 10.0¢ | 9.6¢ | $5.703K | 58.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.41pm 11/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |